See all
 |
Articles: Gynecologic Oncology |
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
British Journal of Cancer, 11/20/09
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
British Journal of Cancer, 11/20/09 In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
British Journal of Cancer, 11/20/09
Prior Articles
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors
Journal of Clinical Oncology, 11/19/09 Minimal deviation mucinous adenocarcinoma (adenoma malignum) of the uterine corpus
Pathology International, 11/19/09 Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue
Virchows Archiv, 11/19/09 Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort
Virchows Archiv, 11/17/09 Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma
Oncology (Karger), 11/17/09 Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology, 11/17/09 Exclusive Author Commentary Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09 A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
Annals of Oncology, 11/16/09 APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09 Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
Cancer Science, 11/16/09 Relationship between NFKB1 –94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk
Annals of Oncology, 11/16/09 Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Journal of Clinical Oncology, 11/13/09 Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer
Anticancer Research, 11/13/09 Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype
American Journal of Epidemiology, 11/13/09 Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
British Journal of Cancer, 11/13/09 Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells
BMC Cancer, 11/13/09
Free full text
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
British Journal of Cancer, 11/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|